These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15482267)

  • 1. Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital.
    Loi S; Haydon AM; Shapiro J; Schwarz MA; Schneider HG
    Intern Med J; 2004; 34(9-10):545-50. PubMed ID: 15482267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of local guidelines on the tumour marker requesting patterns of a General Surgery Department.
    Schulenburg-Brand D; Kumar N; Zouwail S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):438-42. PubMed ID: 23828945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of tumour marker utilization in Greece.
    Ntaios G; Hatzitolios A; Chatzinikolaou A; Karalazou P; Savopoulos C; Karamouzis M; Pidonia I
    Eur J Intern Med; 2009 May; 20(3):e66-9. PubMed ID: 19393482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cardiopulmonary resuscitation on levels of tumour markers.
    Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
    Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour marker requesting in primary care and the role of the laboratory.
    Walker PL; Crook M
    J Clin Pathol; 2011 May; 64(5):443-6. PubMed ID: 21270062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indicators of inappropriate tumour marker use through the mining of electronic health records.
    Gion M; Cardinali G; Trevisiol C; Zappa M; Rainato G; Fabricio ASC
    J Eval Clin Pract; 2017 Aug; 23(4):895-902. PubMed ID: 28503788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Timor J; Thambyrajah V
    Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
    Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9.
    Chester SJ; Maimonis P; Vanzuiden P; Finklestein M; Bookout J; Vezeridis MP
    Dis Markers; 1991; 9(5):265-71. PubMed ID: 1724634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
    Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
    Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
    Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The tumor markers CEA, AFP and CA125 in patients with endometrial carcinoma].
    Gorchev G; Milkov V; Popov I
    Akush Ginekol (Sofiia); 1992; 31(1):22-5. PubMed ID: 1285257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
    Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
    Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological variation and reference change values of CA 19-9, CEA, AFP in serum of healthy individuals.
    Erden G; Barazi AO; Tezcan G; Yildirimkaya MM
    Scand J Clin Lab Invest; 2008; 68(3):212-8. PubMed ID: 17926198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Tao LY; Cai L; He XD; Liu W; Qu Q
    Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.